BIO International Convention 2025

Meet Myllia's CSO Tilmann Buerckstuemmer and BDM Henrik Schmidt at BIO 2025

Join Tilmann Buerckstuemmer and Henrik Schmidt at the BIO 2025! Are you interested in immunology and inflammation (I&I), with a particular focus on target discovery in primary myeloid cells?

If so, please get in touch with Myllia directly:

We’ve developed VISTA – the new CRISPR screening platform enabling target discovery in primary human macrophages and dendritic cells!

Event website:
BIO 2025

Press release about Myllia’s VISTA platform (June 6, 2025):
Myllia unveils the VISTA platform enabling CRISPR screens in human myeloid cells

Attendee(s):
Tilmann Buerckstuemmer (LinkedIn)
Henrik Schmidt (LinkedIn)